Can Canafenib be reimbursed by medical insurance?

Canafenib (Braftovi) is a targeted therapy drug mainly used to treat cancers with specific genetic mutations. Specifically, it targets unresectable or metastatic melanoma with BRAF V600E or V600K mutations, and metastatic colorectal cancer with BRAF V600E mutations. In these cancer types, specific mutations in the BRAF gene cause cells to proliferate out of control, leading to cancer.

Canafenib blocks the signaling pathway of abnormal proliferation of cancer cells by inhibiting the activity of BRAF kinase. This drug can precisely act on cancer cells carrying BRAF V600E or V600K mutations, slowing or stopping their growth, thereby effectively controlling the progression of cancer.

Canafenib has shown significant efficacy in the treatment of melanoma and colorectal cancer. This drug provides a new treatment option for advanced patients who are unable to undergo surgical resection or have metastasized. Through oral administration, canafenib can be easily incorporated into patients' daily treatment regimens.

However, it is important to note that canafenib does not work for all patients, and its efficacy depends on whether the patient's cancer carries a specificBRAF mutation. Therefore, before using canafenib, doctors will perform genetic testing on patients to determine whether they are candidates for the drug.

Canafenib is not currently on the market in China, and domestic patients cannot directly purchase this drug for the time being. It is reported that the drug has been launched in the European market, with the price of 75mg and 42 pills being about 17,000 yuan, while the price of 75mg and 168 pills is as high as about 59,000 yuan. If a patient needs to purchase Canafenib, please be sure to inquire through formal overseas medical consultation channels.

Overall, canafenib is an important targeted therapy that offers new treatment hope for patients with melanoma and colorectal cancer who carry specificBRAF mutations. By acting precisely on cancer cells, it helps control disease progression and improve patients' quality of life.